References
- Birkedal‐Hansen H., Moore W. G., Bodden M. K., Windsor L. J., Birkedal‐Hansen B., DeCarlo A., et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4: 197–250
- Belleguic C., Corbel M., Germain N., Léna H., Boichot E., Delaval P. H., et al. Increased release of matrix metalloproteinase‐9 in the plasma of acute severe asthmatic patients. Clin Exp Allergy 2002; 31: 217–23
- Tang L. F., Du L. Z., Chen Z. M., Zou C. C. The extracellular matrix remodeling in children with airway foreign body aspiration. Pediatr Pulmonol 2004; 38: 140–5
- Sorbi D., French D. L., Nuovo G. J., Kew R. R., Arbeit L. A., Gruber B. L. Elevated levels of 92‐kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis. Arthritis Rheum 1996; 39: 1747–53
- Chua P. K., Meish M. E., Yu Q., Yanagihara R., Yamamoto K. S., Nerurkar V. R. Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease. Clin Diagn Lab Immunol 2003; 110: 308–14
- Nikkari S. T., Hoyhtya M., Isola J., Nikkari T. Macrophages contain 92‐KD gelatinase (MMP‐9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol 1996; 149: 1427–33
- Vogler C., Eliason S. C., Wood E. G. Glomerular membranopathy in children with IgA nephropathy and Henoch–Schönlein purpura. Pediatr Dev Pathol 1999; 2: 227–35
- Muslu A., Islek I., Gok F., Aliyazicioglu Y., Dagdemir A., Dundaroz R., et al. Endothelin levels in Henoch–Schönlein purpura. Pediatr Nephrol 2002; 17: 920–5
- Feldmann R., Rieger W., Sator P. G., Gschnait F., Breier F. Henoch–Schönlein purpura during pregnancy with successful outcome for mother and newborn. BMC Dermatology 2002; 2: 1
- Helander S. D., De Castro F. R., Gibson L. E. Henoch–Schönlein purpura: clinicopathologic correlation of cutaneous vascular IgA deposits and relationship to leukocytoclastic vasculitis. Acta Derm Venereol 1995; 75: 125–9
- Cassidy J., Petty R. Vasculitis. Textbook of pediatric rheumatology 3, J Cassidy, R Petty. WB Saunders, Philadelphia 1995; 365–422
- Urushihara M., Kagami S., Kuhara T., Tamaki T., Kuroda Y. Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis. Nephrol Dial Transplant 2002; 17: 1189–96
- Tashiro K., Koyanagi I., Ohara I., Ito T., Saitoh A., Horikoshi S., Tomino Y. Levels of urinary matrix metalloproteinase‐9 (MMP‐9) and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal 2004; 18: 206–10
- Rao V. H., Lees G. E., Kashtan C. E., Nemori R., Singh R. K., Meehan D. T., et al. Increased expression of MMP‐2, MMP‐9 (type IV collagenases/gelatinases), and MT1‐MMP in canine X‐linked Alport syndrome (XLAS). Kidney Int 2003; 63: 1736–48
- Rai A., Nast C., Adler S. Henoch–Schönlein purpura nephritis. J Am Soc Nephrol 1999; 10: 2637–44